IGBA introductory statement at the Geneva Trilateral Symposium on The Covid 19 Pandemic: Response, Preparedness, Resilience, convened by WHO, WIPO and WTO (December 2022)
The International Generic and Biosimilar Medicines Association is an international organization of national and regional associations representing manufacturers of generic and biosimilar medicines from around the world. Our industry supplies an estimated 80% of all quality-assured medicines globally and is therefore absolutely critical to ensuring safe and affordable medicines are available to patients worldwide and indispensable for achieving Universal Health Coverage.
